Can-Fite BioPharma Ltd. (CANF) › Shareholders' EquityCan-Fite BioPharma Ltd. (CANF) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $2.98M2018: $3.02M2019: $2.44M2020: $6.07M2021: $14.38M2022: $4.47M2023: $6.24M2024: $5.44M2025: $5.59M$5.59M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$5.59M+2.9%2024$5.44M-12.9%2023$6.24M+39.6%2022$4.47M-68.9%2021$14.38M+136.8%2020$6.07M+148.7%2019$2.44M-19.0%2018$3.02M+1.0%2017$2.98M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share